2024
|
P/S
|
Pharmaceuticals and pharmaceutical preparations for the treatment of medical disorders, namely, i... |
|
P/S
|
Pharmaceuticals and pharmaceutical preparations for the
treatment of medical disorders, namely, ... |
2023
|
Invention
|
Polymorphic forms of st-246 and methods of preparation.
Polymorph forms of 4-trifluoromethyl-N-(... |
|
P/S
|
Pharmaceuticals and pharmaceutical preparations; anti-viral pharmaceutical to prevent and/or trea... |
2022
|
Invention
|
St-246 (tecovirimat monohydrate) suspension formulations. The present invention is directed to a ... |
2020
|
Invention
|
Polymorphic forms of st-246 and methods of preparation. Polymorph forms of 4-trifluoromethyl-N-(3... |
|
Invention
|
St-246 liquid formulations and methods. The present invention provides for a novel liquid formula... |
2019
|
Invention
|
Rehydration of micronized tecovirimat monohydrate. Disclosed are methods for hydration of ST-246 ... |
2018
|
Invention
|
Methods of preparing tecovirimat. Disclosed are methods for the preparation of Tecovirimat for th... |
|
Invention
|
Inhibitors and methods of inhibiting bacterial and viral pathogens.
Compounds, pharmaceutical co... |
|
Invention
|
Amorphous tecovirimat preparation. Disclosed are methods for the preparation of amorphous N-[(3aR... |
2017
|
Invention
|
St-246 ( tecovirimat monohydrate) suspension formulations. The present invention is directed to a... |
|
Invention
|
Thienopyridine derivatives for the treatment and prevention of dengue virus infections.
Methods ... |
2016
|
Invention
|
Inhibitors and methods of inhibiting bacterial and viral pathogens. Compounds, pharmaceutical com... |
|
Invention
|
Antiviral drugs for treatment or prevention of dengue infection.
Compounds, methods and pharmace... |
2015
|
Invention
|
Small molecule inhibitors for the treatment or prevention of dengue virus infection.
Methods and... |
|
P/S
|
Anti-viral pharmaceutical to prevent and/or treat orthopoxvirus-related diseases. |
|
Invention
|
Treatment and prevention of dengue virus infections.
Methods and pharmaceutical compositions for... |
2014
|
Invention
|
Rehydration of micronized tecovirmimat monohydrate. Disclosed are methods for hydration of ST-246... |
|
P/S
|
Anti-viral pharmaceutical to prevent and/or treat orthopoxvirus-related diseases |
|
Invention
|
Amorphous tecovirimat preparation. Disclosed are methods for the preparation of amorphous N- [(3a... |
|
Invention
|
Orthopoxvirus infections and associated diseases. Methods of using di, tri, and tetracyclic acylh... |
2013
|
Invention
|
Thienopyridine derivatives for the treatment and prevention of dengue virus infections. Methods a... |
|
Invention
|
Methods of preparing tecovirimat. ABSTRACT Disclosed are methods for the preparation of Tecovirim... |
|
Invention
|
Methods of preparing tecovirimat. Disclosed are methods for the preparation of Tecovirimat ... |
|
Invention
|
Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and ... |
|
Invention
|
Antiviral drugs for treatment or prevention of dengue infection. Compounds, methods and pharmaceu... |
|
Invention
|
Antiviral drugs for treatment of arenavirus infection. Compounds, methods and pharmaceutical comp... |
2011
|
Invention
|
St-246 liquid formulations. The present invention provides for a novel liquid formulation for sol... |
2008
|
P/S
|
Pharmaceuticals and pharmaceutical preparations; pharmaceuticals and pharmaceutical preparations ... |
2007
|
P/S
|
Pharmaceutical research and development services in the fields of biodefense, bacteriology, virol... |
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for the prevention and/or treatment of o... |